QUICK SPARK: UnitedHealth Calls 2026 the Bottom for Medicaid Margins
UnitedHealth expects Medicaid margins to bottom in 2026 and improve through 2028, UnitedHealthcare CEO Tim Noel says on earnings call.
Stocks · News reference
UBS Maintains Neutral on Humana, Raises Price Target to $495
UBS analyst A.J. Rice maintains Humana (NYSE:HUM) with a Neutral and raises the price target from $405 to $495.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Humana To Rally Over 14%? Here Are 10 Top Analyst Forecasts For Tuesday
Analysts cut targets for Duke, Hyatt, Pershing Square, Carlisle, Upstart, Arch Capital and Meta; raised VF, Rexford and SentinelOne.
Mizuho Maintains Outperform on Humana, Raises Price Target to $495
Mizuho analyst Ann Hynes maintains Humana (NYSE:HUM) with a Outperform and raises the price target from $468 to $495.
Humana Forms JV With BlackRock To Manage And Operate Existing Network Of CenterWell Senior Primary Care Clinics; Reaffirms FY26 Adjusted EPS Guidance
Humana Inc. (the "Company") issued a press release today reporting its entry into a new joint venture arrangement with funds and accounts managed by HPS Investment Partners, a subsidiary of BlackRock, Inc.